"Le Centre Antoine Lacassagne est multi-sites, nous vous invitons à bien vérifier l’adresse de votre rdv."

During the past decade, Centre Antoine Lacassagne conducted 227 clinical trials. In the 10-year time frame, 227 clinical trials started and 36 clinical trials were completed, i.e. on average, 15.9% percent of trials that started reached the finish line to date. In the past 5 years, 77 clinical trials started and 26 clinical trials were completed. i.e. 33.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre Antoine Lacassagne" #1 sponsor was "UNICANCER" with 86 trials, followed by "Centre Antoine Lacassagne" with 47 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 29 trials sponsored, "Centre Leon Berard" with 25 trials sponsored and "Centre Oscar Lambret" with 25 trials sponsored. Other sponsors include 232 different institutions and companies that sponsored additional 99 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Antoine Lacassagne" #1 collaborator was "AstraZeneca" with 14 trials as a collaborator, "National Cancer Institute, France" with 13 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 9 trials as a collaborator, "Hoffmann-La Roche" with 8 trials as a collaborator and "GlaxoSmithKline" with 7 trials as a collaborator. Other collaborators include 275 different institutions and companies that were collaborators in the rest 194 trials.

According to Clinical.Site data, the most researched conditions in "Centre Antoine Lacassagne" are "Breast Cancer" (40 trials), "Prostate Cancer" (12 trials), "Head and Neck Cancer" (11 trials), "Cancer" (10 trials) and "Metastatic Breast Cancer" (10 trials). Many other conditions were trialed in "Centre Antoine Lacassagne" in a lesser frequency.

Most popular intervention types in "Centre Antoine Lacassagne" are "Drug" (307 trials), "Radiation" (71 trials), "Other" (66 trials), "Procedure" (49 trials) and "Biological" (37 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (30 trials), "Placebo" (21 trials), "Paclitaxel" (19 trials), "Atezolizumab" (16 trials) and "Gemcitabine" (16 trials). Other intervention names were less common.

The vast majority of trials in "Centre Antoine Lacassagne" are 332 trials for "All" genders, 80 trials for "Female" genders and 26 trials for "Male" genders.

Currently, there are NaN active trials in "Centre Antoine Lacassagne". 5 are not yet recruiting, 95 are recruiting, 73 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 197 completed trials in Centre Antoine Lacassagne, 1 suspended trials, and 40 terminated clinical trials to date.

Out of the total trials that were conducted in Centre Antoine Lacassagne, 33 "Phase 1" clinical trials were conducted, 160 "Phase 2" clinical trials and 155 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 75 trials that are defined as “Not Applicable".

Centre Antoine Lacassagne has several departments that took part in Clinical trials: "Centre Antoine Lacassagne / Oncologie Médicale" - 6 trials, "Centre Antoine Lacassagne Dpt d'Oncologie Médicale" - 2 trials